Food & Food Contact Materials
CIRS Group
Chemicals
Food
Cosmetic
Medical Devices
Agrochemicals
Biocides
Carbon Neutrality
Testing
Search
Meet our global food regulatory team at leading 2026 industry events worldwide. Explore our events calendar and book a meeting.
To help companies respond to these policy changes, CIRS Group, together with HPA-Global, is to host a free webinar on the Policy Trends in Cross-Border E-Commerce for Imported Health Foods & Blue Hat Registration and Filing on Wednesday, 12:00-13:00 pm (EST), August 12, 2026.
In the first half of 2026, China’s National Health Commission (NHC) issued two “Three New Foods” announcements (Announcement No. 1 and Announcement No. 5 of 2026), approving a total of 38 products, including new food raw materials, new food additives, and new food-related products. Among these, 18 were approved as new food additives.
On July 13, 2026, China National Center for Food Safety Risk Assessment (CFSA) issued 4 new food materials. Comments are welcomed before August 12, 2026.
On July 6, Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. (Hengyuan) received a "no questions" letter from the FDA regarding the GRAS (Generally Recognized as Safe) notice for its D-psicose. Produced via an enzymatic bioconversion process, the ingredient's safety has now been officially recognized by the FDA.
In the first half of 2026, China’s National Health Commission (NHC) issued two “Three New Foods” announcements (Announcement No. 1 and Announcement No. 5 of 2026), approving a total of 38 products, including new food raw materials, new food additives, and new food-related products. Among these, 12 were approved as new food raw materials. In addition, seven new food ingredients were added to the Termination of Review List, while five new food ingredients entered the public consultation stage.
China NHC issued notifications regarding the acceptance of “three new foods”. The applications for 2 new food materials and 1 new food additives have been received.
In order to help enterprises better understand the filing status of health food (dietary supplements) in China, CIRS has gathered statistics on health foods approved in 2026 (as of June 30) and analyzed them from multiple perspectives.
With the first half of 2026 concluded, Chinese ingredient companies are demonstrating strong momentum in GRAS notices; the number of approvals secured in this period alone (16) rivals the total for the entire year of 2025 (19). Drawing on publicly available FDA GRAS notice data, CIRS Group has compiled updates from January to June. By systematically reviewing metrics such as total volume, ingredient categories, outcomes, and the origins of applicants, CIRS provides valuable insights for food ingredient companies looking to enter the U.S. market.
LEARN MORE